keyword
https://read.qxmd.com/read/38617375/infantile-epileptic-spasms-syndrome-in-a-child-with-lissencephaly-associated-with-de-novo-pafah1b1-v-ariant-and-coincidental-cmv-infection
#1
Nga Ying Eng, Duyu A Nie
Type 1 lissencephaly is a brain malformation characterized by agyria and pachygyria and is known to be caused by congenital infections and genetic variations. Here we present a case of a 4-month-old female with new onset infantile epileptic spasms syndrome (IESS) with initial etiology concerned for congenital cytomegalovirus (cCMV) due to a positive urine CMV PCR and maternal viral syndrome during pregnancy. Her brain MRI was significant for type 1 lissencephaly without other radiographical features of cCMV...
2024: Epilepsy & behavior reports
https://read.qxmd.com/read/38508705/-zfhx3-variants-cause-childhood-partial-epilepsy-and-infantile-spasms-with-favourable-outcomes
#2
JOURNAL ARTICLE
Ming-Feng He, Li-Hong Liu, Sheng Luo, Juan Wang, Jia-Jun Guo, Peng-Yu Wang, Qiong-Xiang Zhai, Su-Li He, Dong-Fang Zou, Xiao-Rong Liu, Bing-Mei Li, Hai-Yan Ma, Jing-Da Qiao, Peng Zhou, Na He, Yong-Hong Yi, Wei-Ping Liao
BACKGROUND: The ZFHX3 gene plays vital roles in embryonic development, cell proliferation, neuronal differentiation and neuronal death. This study aims to explore the relationship between ZFHX3 variants and epilepsy. METHODS: Whole-exome sequencing was performed in a cohort of 378 patients with partial (focal) epilepsy. A Drosophila Zfh2 knockdown model was used to validate the association between ZFHX3 and epilepsy. RESULTS: Compound heterozygous ZFHX3 variants were identified in eight unrelated cases...
March 20, 2024: Journal of Medical Genetics
https://read.qxmd.com/read/38411568/efficacy-and-safety-of-corticosteroids-and-acth-in-epileptic-syndromes-beyond-infantile-epileptic-spasms-syndrome-iess-a-systematic-review-and-meta-analysis
#3
REVIEW
Rudolf Korinthenberg, Thomas Bast, Edda Haberlandt, Ulrich Stephani, Adam Strzelczyk, Gerta Rücker
We conducted a systematic review investigating the efficacy and tolerability of adrenocorticotropic hormone (ACTH) and corticosteroids in children with epilepsies other than infantile epileptic spasm syndrome (IESS) that are resistant to anti-seizure medication (ASM). We included retrospective and prospective studies reporting on more than five patients and with clear case definitions and descriptions of treatment and outcome measures. We searched multiple databases and registries, and we assessed the risk of bias in the selected studies using a questionnaire based on published templates...
February 27, 2024: Epilepsia
https://read.qxmd.com/read/38015929/delineating-clinical-and-developmental-outcomes-in-stxbp1-related-disorders
#4
JOURNAL ARTICLE
Julie Xian, Kim Marie Thalwitzer, Jillian McKee, Katie Rose Sullivan, Elise Brimble, Eryn Fitch, Jonathan Toib, Michael C Kaufman, Danielle deCampo, Kristin Cunningham, Samuel R Pierce, James Goss, Charlene Son Rigby, Steffen Syrbe, Michael Boland, Benjamin Prosser, Nasha Fitter, Sarah M Ruggiero, Ingo Helbig
STXBP1-related disorders are among the most common genetic epilepsies and neurodevelopmental disorders. However, the longitudinal epilepsy course and developmental end points, have not yet been described in detail, which is a critical prerequisite for clinical trial readiness. Here, we assessed 1281 cumulative patient-years of seizure and developmental histories in 162 individuals with STXBP1-related disorders and established a natural history framework. STXBP1-related disorders are characterized by a dynamic pattern of seizures in the first year of life and high variability in neurodevelopmental trajectories in early childhood...
November 28, 2023: Brain
https://read.qxmd.com/read/37928142/case-report-de-novo-variant-of-setd1a-causes-infantile-epileptic-spasms-syndrome
#5
Mingping Lan, Yanjuan Wang, Sixiu Li, Lili Zhao, Ping Liu, Wenguang Hu
Infantile epileptic spasms syndrome (IESS) is one of the most common epileptic encephalopathies of infancy, with typical clinical features defined by a triad of epileptic spasms, hypsarrhythmia, and developmental delay. Genetic factors are important causes of IESS. The SETD1A (SET Domain Containing 1A) gene encodes a histone lysine methyltransferase that activates gene transcription through histone H3 lysine K4 methylation. Mutations in the SETD1A gene have been associated with schizophrenia, and some have been reported to cause seizures...
2023: Frontiers in Neurology
https://read.qxmd.com/read/37536293/a-heterozygous-variant-of-fgf13-caused-x-linked-developmental-and-epileptic-encephalopathy-90-in-a-chinese-family
#6
Haiying Cheng, Pu Miao, Ye Wang, Yufan Guo, Liuyan Gao, Yuting Lou, Fan Yang, Mengmeng Liang, Jianhua Feng
Developmental and epileptic encephalopathy (DEE) refers to a group of severe epilepsy encephalopathy and development disorders, and its typical clinical features include seizures, drug resistance, and developmental delay or regression. To date, limited studies have reported DEEs driven by FGF13. Here, we reported a girl with DEE90 caused by variant of FGF13. Her electroencephalography (EEG) showed discontinuous hypsarrhythmia, and a heterozygous nonsynonymous variant in FGF13 [NM_004114.4: c.5C>G, p...
August 3, 2023: Cytogenetic and Genome Research
https://read.qxmd.com/read/36882827/genotype-phenotype-correlations-of-stxbp1-pathogenic-variants-and-the-treatment-choices-for-stxbp1-related-disorders-in-china
#7
JOURNAL ARTICLE
Miriam Kessi, Baiyu Chen, Li-Dan Shan, Ying Wang, Lifen Yang, Fei Yin, Fang He, Jing Peng, Guoli Wang
BACKGROUND: We aimed to analyze the genotype-phenotype correlations of STXBP1 pathogenic variants, prognostic factors and the treatment choices in a case-series of STXBP1-related disorders from China. METHODS: The clinical data and genetic results of the children diagnosed with STXBP1-related disorders at Xiangya hospital from 2011 to 2019 were collected retrospectively, and analyzed. We divided our patients into groups for comparison purposes: patients with missense variants and nonsense variants, patients who are seizure-free and not seizure-free, patients with mild to moderate intellectual disability (ID) and severe to profound global developmental delay (GDD)...
March 7, 2023: BMC Medical Genomics
https://read.qxmd.com/read/36278550/mutation-in-the-stxbp1-gene-associated-with-early-onset-west-syndrome-a-case-report-and-literature-review
#8
Kanako Takeda, Yusaku Miyamoto, Hisako Yamamoto, Toshiyuki Iwasaki, Noriko Sumitomo, Eri Takeshita, Atsushi Ishii, Shinichi Hirose, Naoki Shimizu
Syntaxin-binding protein1 ( STXBP1 ) is a member of the Sec1/Munc18-1 protein family, which comprises important regulators of the secretory and synaptic vesicle fusion machinery underlying hormonal and neuronal transmission, respectively. STXBP1 pathogenic variants are associated with multiple neurological disorders. Herein, we present the case of a Japanese girl with a mutation in the STXBP1 gene, who was born at 40 weeks without neonatal asphyxia. At 15 days old, she developed epilepsy and generalized seizures...
September 20, 2022: Pediatric Reports
https://read.qxmd.com/read/36263394/a-retrospective-cohort-study-of-combined-therapy-in-west-syndrome-associated-with-trisomy-21
#9
JOURNAL ARTICLE
Luciana de Paula Souza, Beatriz Bagatin Bermudez, Danielle Caldas Bufara, Ana Chrystina de Souza Crippa
Background: West syndrome (WS) is a frequent epileptic encephalopathy associated with Down syndrome (DS). This study evaluated an outpatient protocol for WS in patients with DS who received vigabatrin (VGB) or VGB plus adrenocorticotrophic hormone. Methods: We analyzed infants treated in two neuropediatric centers from 2001-2021. We reviewed perinatal and familial history of epilepsy, spasm onset, treatment lag, electroencephalogram, neuroimaging, progression to epilepsy, and other neurological conditions. The outcomes were electroclinical resolution (ECR), relapses, and epilepsy progression...
2022: Child Neurology Open
https://read.qxmd.com/read/36158964/case-report-a-novel-ppp3ca-truncating-mutation-within-the-regulatory-domain-causes-severe-developmental-and-epileptic-encephalopathy-in-a-chinese-patient
#10
Jieling Li, Jie Cao
Introduction: Developmental and epileptic encephalopathy 91 (DEE91; OMIM#617711) is a severe neurodevelopmental disorder caused by heterozygous PPP3CA variants. To the best of our knowledge, only a few DEE91 cases have been reported. Results: This study reports a boy who experienced recurrent afebrile convulsions and spasms at the age of 2 months. After being given multiple antiepileptic treatments with levetiracetam, adrenocorticotropic hormone (ACTH), prednisone, topiramate, and clonazepam, his seizures were not completely relieved...
2022: Frontiers in Neurology
https://read.qxmd.com/read/36081241/clinical-and-electroencephalography-characteristics-of-41-children-with-epileptic-spasms-onset-after-1-year-of-age
#11
JOURNAL ARTICLE
Lisi Yan, Yu Deng, Jin Chen, Yue Hu, Siqi Hong, Li Jiang
The incidence of epileptic spasms (ES) that begin after the first year of life is much lower than that before 1 year of age. The aim of this study was to identify clinical and electroencephalography (EEG) characteristics, etiologies, treatments, and prognoses in pediatric patients with ES onset after 1 year of age. Forty-one children were retrospectively identified in Children's Hospital of Chongqing Medical University between January 1, 2020 and December 1, 2021. ES onset after 1 year of age have diverse presentations...
September 5, 2022: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/35887274/an-epilepsy-associated-mutation-of-salt-inducible-kinase-1-increases-the-susceptibility-to-epileptic-seizures-and-interferes-with-adrenocorticotropic-hormone-therapy-for-infantile-spasms-in-mice
#12
JOURNAL ARTICLE
Bo Pang, Takuma Mori, Moataz Badawi, Mengyun Zhou, Qi Guo, Emi Suzuki-Kouyama, Toru Yanagawa, Yoshinori Shirai, Katsuhiko Tabuchi
Six mutations in the salt-inducible kinase 1 (SIK1) have been identified in developmental and epileptic encephalopathy (DEE-30) patients, and two of the mutations are nonsense mutations that truncate the C-terminal region of SIK1. In a previous study, we generated SIK1 mutant (SIK1-MT) mice recapitulating the C-terminal truncated mutations using CRISPR/Cas9-mediated genome editing and found an increase in excitatory synaptic transmission and enhancement of neural excitability in neocortical neurons in SIK1-MT mice...
July 18, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/35788069/melatonin-supplementation-for-the-treatment-of-infantile-spasms-protocol-for-a-randomised-placebo-controlled-triple-blind-trial
#13
JOURNAL ARTICLE
Yulin Sun, Weiwei Feng, Jian Chen, Miao Liu, Xiuyu Shi, Jing Wang, Liping Zou, Tao Xu, Guang Yang
INTRODUCTION: Infantile spasms (IS) is a type of severe epileptic encephalopathy that occurs in infancy and early childhood. IS is characterised clinically by epileptic spasms, often accompanied by sleep disorder and abnormal circadian rhythm. The endogenous circadian rhythm disorder, in turn, can make spasms worse. Melatonin has also been found to have anticonvulsant and neuroprotective properties by adjusting the circadian rhythm. However, there are lack of relevant studies on controlling IS by using melatonin...
July 4, 2022: BMJ Open
https://read.qxmd.com/read/35730569/targeted-gut-microbiota-manipulation-attenuates-seizures-in-a-model-of-infantile-spasms-syndrome
#14
JOURNAL ARTICLE
Chunlong Mu, Naghmeh Nikpoor, Thomas A Tompkins, Anamika Choudhary, Melinda Wang, Wendie N Marks, Jong M Rho, Morris H Scantlebury, Jane Shearer
Infantile spasms syndrome (IS) is a devastating early-onset epileptic encephalopathy associated with poor neurodevelopmental outcomes. When first-line treatment options, including adrenocorticotropic hormone and vigabatrin, are ineffective, the ketogenic diet (KD) is often employed to control seizures. Since the therapeutic impact of the KD is influenced by the gut microbiota, we examined whether targeted microbiota manipulation, mimicking changes induced by the KD, would be valuable in mitigating seizures...
June 22, 2022: JCI Insight
https://read.qxmd.com/read/35087722/pulse-methylprednisolone-with-oral-prednisolone-versus-adrenocorticotropic-hormone-in-children-with-west-syndrome-a-randomized-controlled-trial
#15
JOURNAL ARTICLE
Kanij Fatema, Mizanur Rahman, Mohammad Monir Hossain, Shaheen Akhter, Dewan Afsana Shomee, Sohela Akhter, Mazharul Mannan
BACKGROUND AND PURPOSE: West syndrome is an epileptic encephalopathy of infancy. According to guidelines, adrenocorticotrophic hormone (ACTH) is probably effective for the short-term management of infantile spasm, but there is little uniformity in treatment due to variable response. This study has been done to evaluate the efficacy of pulse methylprednisolone as compared to ACTH in children with West syndrome. METHODS: Children between 3 months to 24 months with the diagnosis of West syndrome were included and ACTH and pulse methyl prednisolone followed by oral prednisolone were given after randomization...
December 2021: Journal of Epilepsy Research
https://read.qxmd.com/read/34999500/clinical-profile-treatment-modalities-and-outcomes-in-patients-with-infantile-spasms-a-retrospective-study-from-the-united-arab-of-emirates-uae
#16
JOURNAL ARTICLE
Dina Amin Saleh, Abeera Hassan
BACKGROUND: Infantile spasms (IS) are an epileptic encephalopathy where the prognosis is generally poor, with most patients exhibiting psychomotor retardation or intractable epilepsy. However, it is claimed that early and aggressive treatment is related to better response rate and outcome, especially in patients with idiopathic IS. OBJECTIVE: To investigate different treatment modalities and outcomes in patients with IS attending a pediatric neurology clinic at a specialized neurology center in Abu Dhabi, United Arab Emirates...
February 2022: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/34864379/status-of-epileptic-spasms-a-study-of-21-children
#17
JOURNAL ARTICLE
Roberto Caraballo, Marcos Semprino, Lorena Fasulo, Gabriela Reyes, Santiago Chacón, Adolfo Gallo, Celeste Buompadre
OBJECTIVE: We studied cases with long-lasting epileptic spasms (ES) considered as a spasm status analyzing type of epilepsy, epileptic syndrome, etiology, treatment, and outcome in 21 patients. METHODS: We evaluated the charts of 21 patients seen between June 2006 and July 2017 who met the electroclinical diagnostic criteria of a spasm status. The spasm status was defined as continuous ES lasting 30 min or longer. RESULTS: The type of ES was mixed in nine patients, flexion in seven, and extension in five...
January 2022: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/34862857/adrenal-function-during-long-term-acth-therapy-for-patients-with-developmental-and-epileptic-encephalopathy
#18
JOURNAL ARTICLE
Yuki Ueda, Shuta Fujishige, Takeru Goto, Shuhei Kimura, Noriko Namatame, Masashi Narugami, Sachiko Nakakubo, Midori Nakajima, Kiyoshi Egawa, Naoya Kaneko, Kanako Nakayama, Nozomi Hishimura, Takeshi Yamaguchi, Akie Nakamura, Hideaki Shiraishi
Some patients with developmental and epileptic encephalopathy (DEE) respond to adrenocorticotropic hormone (ACTH) therapy but relapse soon after. While long-term ACTH therapy (LT-ACTH) has been attempted for these patients, no previous studies have carefully assessed adrenal function during LT-ACTH. We evaluated the effectiveness of LT-ACTH, as well as adverse effects (AE), including their adrenal function in three DEE patients. Patients underwent a corticotropin-releasing hormone (CRH) stimulation test during LT-ACTH, and those with peak serum cortisol below 15 μg/dL were considered to be at high risk of adrenal insufficiency (AI)...
March 2022: Epilepsia Open
https://read.qxmd.com/read/34090146/decisive-evidence-of-direct-effect-of-acth-treatment-in-west-syndrome-a-case-report
#19
JOURNAL ARTICLE
Marie Sasaki, Toshiki Takenouchi, Yuri Sakaguchi, Takao Takahashi
No abstract text is available yet for this article.
May 25, 2021: Seizure: the Journal of the British Epilepsy Association
https://read.qxmd.com/read/33490948/association-of-early-onset-epileptic-encephalopathy-with-involuntary-movements-case-series-and-literature-review
#20
Atsuko Arisaka, Mitsuko Nakashima, Satoko Kumada, Kenji Inoue, Hiroya Nishida, Hideaki Mashimo, Hirofumi Kashii, Mitsuhiro Kato, Koichi Maruyama, Akihisa Okumura, Hirotomo Saitsu, Naomichi Matsumoto, Mitsumasa Fukuda
Epileptic-dyskinetic encephalopathies are rare epilepsies characterized by early-onset epileptic encephalopathies (EOEEs) with involuntary movement. Herein, we investigated the impact of gene variants in epileptic-dyskinetic encephalopathies. Four independent patients from four families who exhibited involuntary movements were recruited from Tokyo Metropolitan Neurological Hospital. The inclusion criteria were as follows: onset within 1 year after birth, frequent seizures, severe developmental delay and accompanying involuntary movements...
2021: Epilepsy & behavior reports
keyword
keyword
102384
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.